Adaptive Biotechnologies Corporation
NASDAQADPT put/call ratio hits 4.35 standard deviations above 20-day average at 0.175, signaling extreme options defensiveness ahead of Thursday earnings.
Snapshot as of 6 Aug 2026
Adaptive Biotechnologies reports Thursday with two signals — defensive options positioning and persistent insider selling — both intensifying rather than fading since yesterday's note. The options market is the most…
Adaptive Biotechnologies enters its Thursday earnings release with a striking internal contradiction: the stock has rallied more than 38% year-to-date, yet the company's own founder has been selling aggressively all…
Adaptive Biotechnologies heads into the final days of June with a telling split: options traders are as bullish as they've been all year, yet insiders have been quietly selling into the rally. The options market is the…
Adaptive Biotechnologies enters the post-earnings period with a notable internal tension: short sellers are stepping back, yet the company's own President and COO has been selling shares every single trading day for…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ADPT — free to start on ORTEX.
Sign up for free →Open ADPT on ORTEX